← Eichor
Study identifier: NCT06549621 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy

Condition: Carbon Monoxide Poisoning  ·  Sponsor: University Hospital, Brest

PhaseN/A
Planned participants66
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

Carbon monoxide poisoning is a frequent domestic accident and the leading cause of death from unintentionnal poisoning. Its toxicity is based on the CO binding to hemoglobin and myoglobin, inhibition of mitochondrial cytochrome oxidase, resulting in tissue hypoxia and reduced adenosine triphosphate synthesis and ischemia-reperfusion injury. This study aims to investigate the early and late cardiologic effects of CO in patients treated with hyperbaric oxygen (HBOT) for CO poisoning

This description comes directly from the study's public registry record.

Talk to the study team

anne Henckes  ·  02 98 34 70 98  ·  anne.henckes@chu-brest.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHRU de BrestBrest, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06549621